Hormone dynamics, pharmacokinetics, safety and efficacy of leuprorelin acetate 6-month depot formulation and tamoxifen adjuvant endocrine therapy combination in premenopausal patients with hormone receptor-positive breast cancer

被引：0
|
作者：
Kurebayashi, J.
Toyama, T.
Sumino, S.
Fujimoto, T.
机构：
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[2] Nagoya City Univ Hosp, Nagoya, Aichi, Japan
[3] Takeda Pharmaceut Co Ltd, Osaka, Japan
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-12-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-12-07
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Factors associated with endocrine therapy refusal in hormone receptor-positive breast cancer patients
    Advani, Pooja P.
    Guzman, Ricardo Torres
    Verduzco, Francisco Avila
    Maita, Karla
    Garcia, John
    Eldaly, Abdullah
    Forte, Antonio
    Spaulding, Aaron
    CANCER RESEARCH, 2022, 82 (04)
  • [32] Beliefs and attitudes toward endocrine therapy in patients with hormone receptor-positive breast cancer
    Kim, Yonglan
    Min, Yul Ha
    Lee, Sae Byul
    HEALTH CARE FOR WOMEN INTERNATIONAL, 2021, 42 (7-9) : 1086 - 1097
  • [33] Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis
    He, Peng
    Li, Jing
    Chen, Minyan
    Huang, Meng
    Qiu, Yibin
    Cai, Qindong
    Lin, Yuxiang
    Wang, Chuan
    Fu, Fangmeng
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (01) : 13 - 28
  • [34] Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis
    Peng He
    Jing Li
    Minyan Chen
    Meng Huang
    Yibin Qiu
    Qindong Cai
    Yuxiang Lin
    Chuan Wang
    Fangmeng Fu
    Breast Cancer Research and Treatment, 2024, 203 : 13 - 28
  • [35] Tamoxifen versus aromatase inhibitors as adjuvant therapy in premenopausal women with hormone receptor-positive breast cancer: Effects on sexuality and the female reproductive system
    Skolariki, A.
    Boutis, A.
    Kosmidis, E. K.
    ANNALS OF ONCOLOGY, 2020, 31 : S45 - S45
  • [36] Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study
    Arecco, Luca
    Latocca, Maria Maddalena
    Blondeaux, Eva
    Riccardi, Ferdinando
    Mocerino, Carmela
    Guarneri, Valentina
    Mioranza, Eleonora
    Bisagni, Giancarlo
    Gasparini, Elisa
    Puglisi, Fabio
    Membrino, Alexandro
    Ferro, Antonella
    Adamo, Vincenzo
    Giovanardi, Filippo
    Tamberi, Stefano
    Donati, Sara
    Landucci, Elisabetta
    Biganzoli, Laura
    Piccinini, Sara
    Pastorino, Simona
    de Azambuja, Evandro
    Poggio, Francesca
    Lambertini, Matteo
    Del Mastro, Lucia
    BREAST, 2024, 77
  • [37] Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years
    Wu, Chiao-En
    Chen, Shin-Cheh
    Chang, Hsien-Kun
    Lo, Yung-Feng
    Hsueh, Swei
    Lin, Yung-Chang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (04) : 249 - 256
  • [38] Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)
    Gori, Stefania
    Puglisi, Fabio
    Cinquini, Michela
    Pappagallo, Giovanni
    Frassoldati, Antonio
    Biganzoli, Laura
    Cortesi, Laura
    Fiorentino, Alba
    Angiolini, Catia
    Tinterri, Corrado
    De Censi, Andrea
    Levaggi, Alessia
    Del Mastro, Lucia
    EUROPEAN JOURNAL OF CANCER, 2018, 99 : 9 - 19
  • [39] Factors associated with adherence to adjuvant endocrine therapy in patients with hormone receptor positive breast cancer
    Kim, Jongjin
    Han, Wonshik
    Moon, Hyeong-Gon
    Kim, Min Kyoon
    Lee, Eunshin
    Yoo, Tae-Kyung
    Lee, Han-Byoel
    Kang, Young Joon
    Kim, Yun-Gyoung
    Kim, Tae Ryung
    Noh, Dong Young
    CANCER RESEARCH, 2015, 75
  • [40] The efficacy of neoadjuvant endocrine therapy during the waiting period for surgery in premenopausal hormone receptor positive breast cancer
    Maeda, Y.
    Sato, A.
    Matsumoto, A.
    Ikeda, T.
    Jinno, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1407 - S1407
12345